(UroToday.com) In a plenary session entitled “Advances in Prostate Cancer: Androgen Deprivation Therapy Across the Disease Continuum” held in conjunction with the American Urologic Association Virtual Annual Meeting this evening, Dr. David Penson explored advances in non-metastatic castration resistant prostate cancer (nmCRPC).